"I suspect if the product was proven unsafe as you suggest and this occured at either the burns hospital or the cmax iv trial lab then they would have no choice but to update market in case the news slipped out and they are found to be in breach of rules for not updating market with price sensitive data."
Yes, you would think so. So where are the ferret results? Reporting can be a subjective issue and a company can, to a degree, decide what is reportable and what isn't.
I'm not suggesting that the results were either 'dangerous' or 'ineffective' and clearly, the results to date suggest that, at specific dosages, 327 is neither. Ongoing trials will, no doubt, explore those parameters further, but a pharmaceutical needs to meet many more criteria than that before it is a marketable commodity.
As to James 'relocating' etc. to the US, best I don't comment on that, lest some jittery stakeholder has me censored - again.
"I suspect if the product was proven unsafe as you suggest and...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.030(5.26%) |
Mkt cap ! $116.2M | |||
| Open | High | Low | Value | Volume |
| 59.3¢ | 60.0¢ | 57.0¢ | $117.6K | 206.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 41968 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 6282 | 2 |
View Market Depth
| Last trade - 15.09pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
59.0¢ |
Change
0.030 ( 2.61 %) |
||||
| Open | High | Low | Volume | ||
| 57.5¢ | 59.0¢ | 57.0¢ | 35799 | ||
| Last updated 13.50pm 28/05/2024 ? | |||||
| RCE (ASX) Chart |